NCT03733132View on ClinicalTrials.gov

Metformin Effect on Brain Function in Insulin Resistant Elderly People

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 15, 2019

Primary Completion Date

April 5, 2023

Study Completion Date

April 5, 2023

Conditions
Insulin ResistanceObesityObesity, Abdominal
Interventions
DRUG

Metformin Hydrochloride

Metformin treatment of 2500mg for 10 months in the Metformin group

DRUG

Placebo Oral Tablet

Placebo treatment of identical tablets to metformin group

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Mayo Clinic

OTHER